Latest Breaking News On - Mateon therapeutics - Page 6 : comparemela.com

Oncotelic Provides Update on OT-101 at the 2022 BIO International Convention

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesTecentriq genentechAmit shahKeytruda merckOncotelic therapeutics incMateon therapeutics incPointr data incInternational conventionDrug administrationOxigene incParkinson diseaseMateon therapeuticsNew yorkOncotelic therapeuticsPointr dataErectile dysfunction

Oncotelic Therapeutics Receives FDA Clearance for Phase 2 Clinical Trial of OT-101/Pembroluzimab Combination for Mesothelioma (M201)

Oncotelic Therapeutics Receives FDA Clearance for Phase 2 Clinical Trial of OT-101/Pembroluzimab Combination for Mesothelioma (M201)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAnthonye maidaMelina marmarelisAmit shahDragon overseas capital limitedMesothelioma centerPointr data incDrug administrationUniversity of pennsylvania pleuralPerelman school of medicineOxigene incOncotelic therapeutics incMateon therapeutics incUniversity of pennsylvaniaBiotechnology limitedParkinson disease

ONCOTELIC ANNOUNCES US PATENT GRANT FOR CA4P AND OXI4503 COMBINATION WITH CHECKPOINT INHIBITORS

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesPembrolizumab keytrudaAmit shahVuong trieuPointr data incDrug administrationOxigene incDragon overseas capitalOncotelic therapeutics incMateon therapeutics incUs patent officeVascular disrupting agentJoint ventureDragon overseas capital limitedMateon therapeuticsNew york

Oncotelic Appoints Seymour Fein M D as Chief Regulatory Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesAmit shahVuong trieuSeymour feinRoche ltdPointr data incYork medical collegeDrug administrationHarvard medical schoolOxigene incDragon overseas capitalOncotelic therapeutics incMateon therapeutics incUniversity of pennsylvaniaBayer healthcare pharmaceuticalsRorer group

Oncotelic to Present New Studies on its TGF-β Program at the American Association for Cancer Research (AACR) Annual Meeting 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesNew orleansAmit shahVuong trieuPointr data incDrug administrationOxigene incOncotelic therapeutics incAmerican association for cancer researchTherapeutics incMateon therapeutics incMateon therapeutics inc oncotelicAmerican associationCancer researchAnnual meetingSession category